enzalutamide as treatment for men with mhspc who have received testosterone suppression
Published 5 years ago • 279 plays • Length 3:38Download video MP4
Download video MP3
Similar videos
-
6:06
enzalutamide plus androgen deprivation therapy prolongs survival in men with metastatic hormone-...
-
8:56
enzalutamide improves survival for men with metastatic hormone-sensitive prostate cancer
-
3:43
arches trial: androgen deprivation therapy with enzalutamide or placebo in mhspc
-
1:53
comment: using enzalutamide will allow patients to avoid chemotherapy and steroids improving qua...
-
4:22
fatigue in men with castration resistant prostate cancer treated with enzalutamide
-
2:47
enzamet trial: early enzalutamide delays progression, improves survival in mhspc
-
1:46
stream trial: enzalutamide and androgen deprivation therapy with salvage radiation in men with h...
-
9:48
the transformer study: bipolar androgen therapy vs. enzalutamide in asymptomatic men with mcrpc
-
5:16
enzamet: enzalutamide for metastatic prostate cancer
-
3:13
androgen deprivation therapy plus enzalutamide for hormone-sensitive prostate cancer
-
18:01
clinical updates for metastatic hormone sensitive prostate cancer at asco 2019
-
10:07
pca commentary: sequencing bipolar androgen therapy (bat) with xtandi- an effective option
-
1:03
dr. azad on the benefit of adding enzalutamide to adt in mhspc
-
9:48
adt plus tak-700 with adt plus bicalutamide in patients with newly diagnosed mhspc
-
3:44
the evolving standard of care for patients with metastatic hormone-sensitive prostate cancer
-
2:17
enzalutamide for biochemically recurrent prostate cancer | nejm
-
3:44
updates from the cheiron study: docetaxel plus enzalutamide for mcrpc
-
2:14
prostate cancer: research shows new treatment option offers improved survival
-
9:01
prostate cancer updates: titan and enzamet